Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramsaransing, G. S.M.
Right arrow Articles by De Keyser, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramsaransing, G. S.M.
Right arrow Articles by De Keyser, J.
NEUROLOGY 2004;62:239-242
© 2004 American Academy of Neurology

Peripheral blood leukocyte NO production in MS patients with a benign vs progressive course

Geeta S.M. Ramsaransing, MD, Albert Teelken, PhD, Alexander V. Arutjunyan, PhD Dsci and Jacques De Keyser, MD PhD

From the Department of Neurology (Drs. Ramsaransing, Teelken, and De Keyser), Academisch Ziekenhuis Groningen, the Netherlands; and the Laboratory of Perinatal Biochemistry (Dr. Arutjunyan), D.O. Ott Research Institute, Russian Academy of Medical Sciences, St. Petersburg, Russia.

Address correspondence and reprint requests to Dr. Jacques De Keyser, Department of Neurology, Academisch Ziekenhuis Groningen, Hanzeplein 1, 9713 GZ Groningen, the Netherlands; e-mail: j.h.a.de.keyser{at}neuro.azg.nl

Background: Nitric oxide (NO) may play a role in tissue destruction and axonal degeneration in multiple sclerosis (MS).

Objective: To investigate NO production by peripheral blood leukocytes (PBL) in patients with a benign and progressive course of MS.

Methods: PBL were isolated from 25 patients with a benign course of MS (BMS), 33 with secondary progressive MS (SPMS), 21 with primary progressive MS (PPMS), and 29 healthy individuals. Leukocyte supernatants were assayed for nitrite concentration, which is an index of NO generation, using the Griess reaction. Serum levels of tumor necrosis factor (TNF){alpha} and interleukin (IL)-12 were measured using ELISA.

Results: Compared to healthy controls, nitrite concentrations were higher in patients with BMS (p < 0.001), SPMS (p < 0.001), and PPMS (p < 0.05). There were no significant differences among the three clinical subgroups of MS. There was a correlation between nitrite concentrations and serum levels of IL-12 (p = 0.04), but not of TNF{alpha}.

Conclusion: Increased NO production by PBL in patients with MS is independent of the disease course.


Received August 4, 2003. Accepted in final form September 24, 2003.




This article has been cited by other articles:


Home page
Mult SclerHome page
M. Koch, J. Mostert, A. Arutjunyan, M. Stepanov, A. Teelken, D. Heersema, and J. De Keyser
Peripheral blood leukocyte NO production and oxidative stress in multiple sclerosis
Multiple Sclerosis, March 1, 2008; 14(2): 159 - 165.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G S M Ramsaransing, M R Fokkema, A Teelken, A V Arutjunyan, M Koch, and J De Keyser
Plasma homocysteine levels in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, February 1, 2006; 77(2): 189 - 192.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.